NCT00793026CompletedPhase 3
Safety Dermatological Evaluation: Genital Mucous Irritation - Test in Use - Dermacyd Breeze Pocket BR (Lactic Acid).
Conditions
Interventions
Drugs
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Sanofi
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- Good acceptability
Study Overview
Brief Summary
The purpose of this study is to prove the safety of the gynaecological formulation in normal conditions of use.
Study Design
- Study Type
- Interventional
- Allocation
- Non Randomized
- Intervention Model
- Single Group
- Primary Purpose
- Supportive Care
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 60 Years (Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Arms & Interventions
1
Experimental
Dermacyd Breeze Pocket BR (Lactic Acid)
Intervention: Dermacyd Breeze Pocket BR (Lactic Acid) (Drug)
Outcomes
Primary Outcomes
Good acceptability
Time Frame: Throughout the study
Absence of irritation
Time Frame: Throughout the study
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 3
Dermacyd Femina Pocket BR (Lactic Acid)- Acceptability.HygieneNCT00794612Sanofi30
Completed
Phase 3
Dermacyd PH_DETINLYN Sweet Flower (Lactic Acid) - SafetyHygieneNCT00785148Sanofi31
Completed
Phase 3
Dermacyd PH_DETINLYN Tangerine Mix (Lactic Acid) - Safety.HygieneNCT00785642Sanofi30
Completed
Phase 3
Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower - Safety.HygieneNCT00785850Sanofi31
Completed
Phase 3
Dermacyd PH_DETINBACK Tangerine Mix (Lactic Acid) - Safety.HygieneNCT00783939Sanofi31